30 closest matches · ranked by relevance
Opiate Dependence · Substance-related Disorders · Opioid-related Disorders
Primary: The Number of Participants Attaining Successful Opioid Use Outcome by Counseling Condition at End of Phase 1 — 19; 24 participants
Opioid-use Disorder
Primary: Recruitment Rate — 3; 12; 5 Participants
Opioid-use Disorder · Mental Disorder · Opioid Medication Assisted Treatment
Primary: Number of Participants With Self-reported Treatment Retention — 51 Participants
Opiate-related Disorders
Primary: Hepatic Safety — 278; 318; 41; 62 participants — p=< 0.05
Opioid Dependence
Primary: Completion of OST — 9 participants
HIV Prevention · Opioid-Related Disorders
Primary: Treatment Engagement — 23; 11; 6 participants — p=<0.001
Opiate Dependence · Drug Dependence · Substance Dependence
Primary: Responders at Day 3 — 85; 85; 8; 9 Participants
Low Back Pain
Primary: Analgesia — 36.3; 71.8 units on a VAS scale — p=0.097
Opiate Dependence
Primary: Illicit Opioid Use — 35.2; 53.2 percent of opioid negative urine samples
Opioid-use Disorder
Primary: Treatment Success Rate — 70; 67 Participants — p=0.7326
Opioid Dependence
Primary: Urine Toxicology for Opiate Use — 2; 4; 2; 0 Participants
Opioid Dependence · Opioid Withdrawal
Primary: Area Under the Curve (AUC) in COWS Total Score on Days 1 to 5 Inclusive — 4.2; 3.4 Average COWS score * hours
Opiate-related Disorders · Opiate Dependence · Drug Abuse
Primary: Subject's Self Assessment Using 10 cm Visual Analogue Scale (VAS) of Overall Preference for One of the Two Buprenorphine-based Maintenance Therapies (Suboxone® or…
Opioid-use Disorder
Primary: Buprenorphine Treatment Adherence — 19.7; 16.1 percentage of urine samples — p=0.914
Opioid-Related Disorders · Opiate Dependence · Drug Abuse
Primary: Retention Rate After 12 Months of Treatment With Suboxone — 59.9 % of participants
Opioid-Related Disorders · Heroin Dependence
Primary: The Primary Outcome Will Include a Comparison of the Proportion of Patients Successfully Inducted One Week After the Initial Primary Care Visit. — 6; 6 participants
Opioid-Related Disorders · Opiate Dependence · Drug Abuse
Primary: Retention Rate — 57.3; 45.6 percentage of patients
Chronic Pain · Opioid Addiction · Symptomatic Hypogonadism
Primary: Number of Participants Demonstrating Abstinence — 5; 4 Participants
Opioid Dependence, on Agonist Therapy
Primary: Number of Patients Reporting Treatment-Emergent Adverse Events — 20; 21 participants
Substance Use Disorders
Primary: Participant Acceptability of the Interventions — 1; 0 Participants
Opioid-Related Disorders · Opiate Dependence
Primary: Retention in Treatment in the Per Protocol Population — 113; 122 participants — p=<0.05
Opioid-use Disorder
Primary: Buprenorphine Adherence as Assessed by the Percentage of Buprenorphine-positive Urine Samples — 80; 84; 78 percentage of urine samples — p==0.22
Opioid-use Disorder
Primary: Days of Risky Opioid Use in Past 180 Days — 12.2; 15.5 days
Opiate Addiction
Primary: Buprenorphine Engagement — 19; 19 Participants — p=0.94
Opioid-use Disorder · Opioid Dependence · Opiate Dependence
Primary: Mean Urinary Buprenorphine Levels — 861; 287 ng/ml — p=.1
HIV · Substance Related Disorders
Primary: Number of Participants With HIV Viral Suppression — 97; 92; 74; 99 Participants
Opioid Withdrawal · Physical Dependence
Primary: Change in Objective Opioid Withdrawal Score (OOWS) From Baseline (Prevention of Opioid Withdrawal) — 3.6; 3.6 units on a scale — p=0.87
Opioid-use Disorder
Primary: Number of Participants With Retention in Medication Treatment for OUD — 46; 51 Participants — p=0.94
Opioid Use Disorder
Primary: Time to Relapse (Intent to Treat Population) — 8.4; 14.4 weeks
Opioid-use Disorder
Primary: Sublocade Induction — 10 Participants